Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes
Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.
Health systems use AI to target patients who may have elevated Lp(a) levels
"We can start helping people right now, and it would be meaningful if we can raise more awareness to reduce the burden of CVD," explained Katherine Wilemon, founder and CEO of the Family Heart Foundation.
Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?
Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.
Cardiology group thanks Taylor Swift for spreading word about nuclear stress testing
When Taylor Swift speaks, the world listens. And when she recently appeared on a podcast for the very first time, she shared the story of how a nuclear stress test saved her father's life.

Modifying saturated fat intake helps decrease risk of cardiovascular events by 21%

Limiting saturated fat intake can decrease a person’s risk of adverse cardiovascular events by a significant margin, according to a new systematic review of 15 different studies.

FDA recalls multiple lots of extended-release metformin due to contamination

The FDA is pushing for a voluntary recall of certain lots of extended-release metformin after lab tests revealed unacceptable levels of N-nitrosodimethylamine.

New drug combination could lead to the return of an old diabetes treatment

Rosiglitazone was once a popular treatment for Type 2 diabetes, but it fell out of favor due to a variety of side effects.

The eye-opening connection between heart health and cognitive decline

The World Health Organization estimates that 82 million people will be affected by dementia by the year 2030—could maintaining a healthy heart be one way to keep such conditions at bay?

Sugary drink consumption boosts risk of CVD, stroke in women

Drinking just one sugary drink per day can increase a woman’s risk of cardiovascular disease (CVD) by 19%, according to new findings published in the Journal of the American Heart Association.

Cardiovascular groups share joint guidance on continuation of procedures, diagnostic tests during COVID-19 pandemic

A group of cardiovascular societies, including the American College of Cardiology (ACC) and American Heart Association (AHA), has published a new guidance designed to help providers resume important procedures and diagnostic tests during the COVID-19 pandemic.

New CDC data finds hypertension on the rise—but it’s not what you think

There’s a reason to feel quite optimistic about these numbers—the rise comes from an updated definition of hypertension, one first suggested by the American College of Cardiology and American Heart Association.

Evolocumab associated with significant drop in heart attack risk

Taking evolocumab to lower LDL cholesterol can lead to significant reductions in a patient’s risk of myocardial infarction (MI), according to new findings published by JAMA Cardiology.

Heart Health

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Health systems use AI to target patients who may have elevated Lp(a) levels

Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?

Cardiology group thanks Taylor Swift for spreading word about nuclear stress testing